Wilson Sonsini advised Investor Time BioVentures on the deal while WilmerHale represented Phantom Neuro.Phantom Neuro, the first-of-its-kind neurotech startup that delivers a low power, high accuracy…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
